Geoffrey Canet

Publications

Article dans une revue (9)

Proteostasis restoration: a new metric for tau immunotherapy efficacy Geoffrey Canet,Emmanuel Planel Brain - A Journal of Neurology , 2025, 148 (1), pp.9-11. ⟨10.1093/brain/awae382⟩ Article dans une revue hal-05285461v1
Universal Prime Editing Therapeutic Strategy for RyR1-Related Myopathies: A Protective Mutation Rescues Leaky RyR1 Channel Geoffrey Canet,Felipe da Gama Monteiro,Emma Rocaboy,Sofia Diego-Diaz,Boutheyna Khelaifiaet al. International Journal of Molecular Sciences, 2025, 26 (7), pp.2835. ⟨10.3390/ijms26072835⟩ Article dans une revue hal-05285448v1
Advancing Alzheimer's disease pharmacotherapy: efficacy of glucocorticoid modulation with dazucorilant (CORT113176) in preclinical mouse models Geoffrey Canet,Charleine Zussy,Mathieu Vitalis,Françoise Morin,Nathalie Chevallieret al. British Journal of Pharmacology, 2025, 182 (9), pp.1930-1956. ⟨10.1111/bph.17457⟩ Article dans une revue hal-04928530v1
Beneficial effects of miR-132/212 deficiency in the zQ175 mouse model of Huntington’s disease Behnaz Nateghi,Remi Keraudren,Gabriel Boulay,Marc Bazin,Claudia Goupilet al. Frontiers in Neuroscience, 2024, 18, ⟨10.3389/fnins.2024.1421680⟩ Article dans une revue hal-05285453v1
Age-dependent impact of streptozotocin on metabolic endpoints and Alzheimer's disease pathologies in 3xTg-AD mice Geoffrey Canet,Maud Gratuze,Charleine Zussy,Mohamed Lala Bouali,Sofia Diego Diazet al. Neurobiology of Disease, In press, pp.106526. ⟨10.1016/j.nbd.2024.106526⟩ Article dans une revue hal-04587597v1
Temperature-induced Artifacts in Tau Phosphorylation: Implications for Reliable Alzheimer’s Disease Research Geoffrey Canet,Emma Rocaboy,Francis Laliberté,Emmanuelle Boscher,Isabelle Guisleet al. Experimental Neurobiology, 2023, 32 (6), pp.423-440. ⟨10.5607/en23025⟩ Article dans une revue hal-05285454v1
Intranasal Administration of Nanovectorized Docosahexaenoic Acid (DHA) Improves Cognitive Function in Two Complementary Mouse Models of Alzheimer’s Disease Charleine Zussy,Rijo John,Théo Urgin,Léa Otaegui,Claire Vigoret al. Antioxidants , 2022, 11 (5), pp.838. ⟨10.3390/antiox11050838⟩ Article dans une revue hal-03652818v1
Sauna-like conditions or menthol treatment reduce tau phosphorylation through mild hyperthermia Isabelle Guisle,Geoffrey Canet,Séréna Pétry,Parissa Fereydouni-Forouzandeh,Françoise Morinet al. Neurobiology of Aging, 2022, 113, pp.118-130. ⟨10.1016/j.neurobiolaging.2022.02.011⟩ Article dans une revue hal-05285456v1
Glucocorticoid receptors signaling impairment potentiates amyloid‐β oligomers‐induced pathology in an acute model of Alzheimer’s disease Geoffrey Canet,Fanny Pineau,Charleine Zussy,Célia Hernandez,Hazel Huntet al. FASEB Journal, 2019, 34, pp.1150-1168. ⟨10.1096/fj.201900723RRR⟩ Article dans une revue hal-02407317v1

Chapitre d'ouvrage (3)

Methods for Biochemical Isolation of Insoluble Tau in Rodent Models of Tauopathies Geoffrey Canet,Emma Rocaboy,Sofia Diego-Diàz,Robert Whittington,Carl Julienet al. Tau Protein, 2754, Springer US, pp.323-341, 2024, Methods in Molecular Biology, ⟨10.1007/978-1-0716-3629-9_17⟩ Chapitre d'ouvrage hal-05285466v1
Western Blot of Tau Protein from Mouse Brains Extracts: How to Avoid Signal Artifacts Parissa Fereydouni-Forouzandeh,Geoffrey Canet,Sofia Diego-Diàz,Emma Rocaboy,Serena Petryet al. Tau Protein, 2754, Springer US, pp.309-321, 2024, Methods in Molecular Biology, ⟨10.1007/978-1-0716-3629-9_16⟩ Chapitre d'ouvrage hal-05286874v1
Targeting Glucocorticoid Receptors: A New Avenue for Alzheimer’s Disease Therapy Parissa Fereydouni-Forouzandeh,Geoffrey Canet,Sofia Diego-Diàz,Emma Rocaboy,Serena Petryet al. Pathology, Prevention and Therapeutics of Neurodegenerative Disease, 2754, Springer Singapore; Springer US, pp.173-183, 2019, Methods in Molecular Biology, ⟨10.1007/978-981-13-0944-1_15⟩ Chapitre d'ouvrage hal-05285471v1